User login
- /content/bevacizumab-or-pemetrexed-not-both-efficacious-nsclc-maintenance
- /fedprac/article/206027/lung-cancer/bevacizumab-or-pemetrexed-not-both-efficacious-nsclc-maintenance
- /oncologypractice/article/206027/lung-cancer/bevacizumab-or-pemetrexed-not-both-efficacious-nsclc
- /fedprac/avaho/article/206027/lung-cancer/bevacizumab-or-pemetrexed-not-both-efficacious-nsclc
- /hematology-oncology/article/206027/lung-cancer/bevacizumab-or-pemetrexed-not-both-efficacious-nsclc